CVRX vs AURE Comparison

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Aurelion Inc is a publicly traded company building a digital gold risk and technology infrastructure around XAUT, on-chain gold backed by physical LBMA bars. XAUT combines the stability of physical gold with the efficiency of blockchain, giving investors access to a tokenized gold reserve that could serve as a hedge against inflation, currency devaluation, and crypto volatility. In parallel with building a business around tokenized gold, Aurelion provides wealth and asset management services.